ACRONGENOMICS INC

ACRONGENOMICS INC insiders are currently net buyers of AGNM stock, showing bullish sentiment over the past 90 days. Executives have purchased $480 while selling $65, resulting in a positive net flow of $415. This buying activity represents 88% of total transaction volume.

ACRONGENOMICS INC has 4 active insiders who have filed SEC Form 4 transactions in the past 90 days. Platon Tzouvales (Executive) leads with 1 transactions totaling $525.0K. Emmanouil Topoglidis (Executive) follows with 1 transactions worth $280.0K. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. ACRONGENOMICS INC's current score of 88/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $480 in purchases versus $65 in sales.

The most recent insider transaction occurred on Apr 27, 2009, when T. Manolis Evan (Executive) acquired 1,500 shares at $0.43 per share for $645. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, AGNM insider trading sentiment is currently bullish with an Alignment Score of 88/100. The net insider flow of $415 reflects accumulation, with 88% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like ACRONGENOMICS INC. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At AGNM, we track all Form 4 filings—currently showing 10 transactions from 4 insiders over 90 days.

A 10b5-1 plan allows ACRONGENOMICS INC executives to pre-schedule stock sales when they don't possess material non-public information. At AGNM, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at AGNM appears discretionary, making insider signals more meaningful.

You can monitor ACRONGENOMICS INC (AGNM) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 4 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. ACRONGENOMICS INC's current score of 88/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $480 in purchases versus $65 in sales over 90 days, resulting in a net flow of $415.

SEC Form 4 filings are mandatory reports that ACRONGENOMICS INC insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At AGNM, the most common type is "J" with 6 occurrences. The most recent Form 4 was filed on Apr 27, 2009 by T. Manolis Evan.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At ACRONGENOMICS INC, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at AGNM represents discretionary decisions with more informational value.